earli
gramneg
sepsi
excess
releas
proinflammatori
cytokin
caus
septic
shock
often
follow
state
immun
paralysi
character
failur
mount
adapt
immun
toward
secondari
microbi
infect
especi
earli
mechan
respons
immun
hyporespons
unclear
show
key
immun
sens
receptor
initi
paralysi
tcell
immun
bacteri
sepsi
downstream
signal
trif
impair
develop
specif
tcell
immun
secondari
infect
identifi
type
interferon
ifn
releas
splenic
macrophag
critic
factor
caus
tcell
immun
paralysi
earli
sepsi
type
ifn
act
select
dendrit
cell
dc
impair
antigen
present
secret
proinflammatori
cytokin
result
reveal
novel
immun
regulatori
role
type
ifn
initi
septic
immun
paralysi
distinct
wellknown
immun
stimulatori
effect
moreov
identifi
potenti
molecular
target
therapeut
intervent
overcom
impair
tcell
immun
sepsi
sepsi
sever
inflammatori
dysregul
aris
situat
infect
confin
local
dissemin
via
blood
stream
septic
inflammatori
respons
compris
two
function
distinct
mutual
exclus
phase
first
system
inflammatori
respons
sir
character
excess
product
proinflammatori
mediat
second
compensatori
antiinflammatori
respons
car
later
phase
sepsi
associ
increas
suscept
secondari
infect
character
sever
impair
adapt
tcell
immun
subsequ
lead
inabl
control
viral
bacteri
infect
may
ultim
lead
multiorgan
failur
cohen
hotchkiss
karl
hotchkiss
et
al
variou
preclin
model
system
develop
uncov
pathophysiolog
cellular
molecular
mechan
respons
sir
car
caecum
ligat
punctur
colon
ascenden
stent
periton
casp
inject
bacteria
tolllik
receptor
tlr
ligand
lp
bura
et
al
use
model
system
becam
clear
sir
car
initi
widespread
activ
innat
immun
cell
consequ
signal
pattern
recognit
receptor
prr
detect
pathogenassoci
molecular
pattern
pamp
beutler
kawai
akira
sir
associ
massiv
secret
trifdepend
proinflammatori
cytokin
ie
tnf
interferon
ifn
g
weighardt
et
al
weighardt
holzmann
car
link
product
regulatori
cytokin
volk
et
al
cohen
involv
dampen
innat
adapt
immun
respons
trinchieri
ogarra
murphi
induc
refractori
phase
macrophag
render
nonrespons
prr
stimul
randow
et
al
serum
level
correl
decreas
level
mhc
class
ii
molecul
defect
tnf
product
monocyt
septic
patient
dock
et
al
volk
et
al
consequ
impair
adapt
cell
ctl
immun
consid
depend
impair
macrophag
initi
tcell
immun
show
type
ifn
exhibit
unexpect
immun
regulatori
role
gener
ctl
immun
type
ifn
produc
local
spleen
macrophag
respons
circul
bacteria
incapacit
dendrit
cell
dc
induc
ctl
immun
subsequ
system
infect
virus
intracellular
bacteria
system
distribut
bacteria
play
essenti
role
induct
sepsi
sir
car
use
wellestablish
murin
sepsi
model
casp
investig
role
bacteri
transloc
circul
septic
immun
paralysi
intragastr
applic
recombin
luciferaseexpress
e
coli
allow
us
directli
visual
rapid
bacteri
spread
surgic
intervent
variou
organ
invivo
bioluminesc
imag
figur
b
base
result
studi
mechan
determin
immun
regul
earli
bacteri
sepsi
end
challeng
mice
surviv
casp
system
viral
infect
use
recombin
adenoviru
express
ovalbumin
adova
determin
subsequ
induct
ovaspecif
tcell
immun
shown
recent
gener
adenovirusinduc
ctl
immun
strictli
depend
antigen
present
dc
spleen
backer
et
al
system
treatment
mice
cpgdna
result
inhibit
ovaspecif
ctl
immun
spleen
wingend
et
al
therefor
reason
system
distribut
bacteria
would
impair
local
induct
antivir
ctl
immun
spleen
quantif
ovaspecif
ctl
respons
day
adova
infect
measur
specif
tcell
cytotox
vivo
reveal
antivir
ctl
immun
strongli
suppress
mice
casp
compar
untreat
mice
figur
support
hypothesi
system
bacteria
suppress
ctl
respons
spleen
mocktreat
mice
undergon
laparatomi
mechan
intestin
manipul
casp
show
bacteri
transloc
liver
lung
littl
bacteri
dissemin
spleen
supplementari
figur
report
previous
mechan
manipul
gut
lead
inflamm
intestin
wall
caus
transloc
gut
bacteria
schwarz
et
al
consequ
bacteria
transloc
liver
lung
reach
spleen
signific
number
mice
develop
impair
ctl
immun
figur
ctl
immun
also
suppress
use
heat
kill
hk
e
coli
treat
e
coliinfect
mice
antibiot
supplementari
figur
assum
suppress
effect
independ
persist
live
bacteria
furthermor
use
defin
number
e
coli
instead
casp
advantag
investig
effect
bacteria
gener
ctl
respons
quantit
manner
thu
possibl
show
system
inject
e
coli
suppress
gener
antivir
ctl
immun
doseand
timedepend
fashion
figur
furthermor
iv
inject
e
coli
casp
treatment
suppress
ctl
respons
similar
fashion
use
iv
inject
e
coli
mimic
sepsi
throughout
manuscript
system
distribut
e
coli
suppress
develop
ctl
immun
recombin
adenovir
antigen
also
herp
simplex
viru
hsv
influenza
viru
l
monocytogen
infect
figur
ctl
immun
infecti
microorgan
requir
spleen
figur
find
suggest
immun
paralysi
observ
gramneg
sepsi
phenomenon
affect
spleendepend
ctl
immun
gener
recent
show
adenoviru
select
infect
metallophil
margin
zone
macrophag
mmm
howev
cell
activ
mmm
rather
dc
receiv
antigen
mmm
far
undefin
transfer
mechan
backer
et
al
exclud
sepsi
ctl
respons
subsequ
bacteri
viral
infect
impair
due
lower
infect
less
antigen
avail
present
infect
adova
substitut
solubl
ova
inde
could
show
septic
mice
also
unabl
mount
ctl
respons
solubl
ova
figur
thu
confirm
hypothesi
sepsi
imped
ctl
immun
directli
impair
tcell
activ
rather
lower
antigen
avail
inhibitori
effect
bacteri
sepsi
restrict
ctl
immun
extend
bcell
respons
requir
tcell
help
system
distribut
e
coli
prior
immun
solubl
ova
plu
stimulatori
antibodi
result
signific
lower
titr
ovaspecif
antibodi
week
supplementari
figur
thu
identifi
system
bacteri
distribut
spleen
critic
event
suppress
develop
antimicrobi
ctl
immun
well
helper
celldepend
antibodi
product
taken
togeth
data
identifi
uniqu
spatiotempor
characterist
immun
paralysi
caus
gramneg
bacteria
impair
spleendepend
tcell
immun
circul
gramneg
bacteria
recogn
variou
prr
tlr
recogn
lipopeptid
recogn
hypomethyl
bacteri
dna
recogn
lipopolysaccharid
wherea
contribut
tlr
system
inflamm
bacteri
dissemin
well
defin
beutler
littl
known
role
inhibit
ctl
immun
mellor
et
al
wilson
et
al
wingend
et
al
led
us
investig
whether
individu
tlr
ligand
inhibit
ctl
immun
similar
inhibitori
effect
e
coli
ligand
ligand
lp
ligand
prevent
induct
antivir
ctl
immun
appli
intraven
day
system
viral
infect
figur
suggest
broad
involv
sever
tlr
regul
e
coli
lux
given
oral
mice
h
casp
bacteri
distribut
measur
quantifi
bioluminesc
imag
indic
time
point
vivo
isol
organ
c
ovaspecif
ctl
immun
determin
vivo
mice
c
underw
casp
mice
receiv
differ
dose
e
coli
differ
time
point
day
iv
challeng
adova
particlesmous
e
iv
inject
e
coli
day
prior
infect
herp
simplex
viru
hsv
pfu
influenza
viru
pfu
l
monocytogen
ctl
immun
determin
day
later
f
mice
splenectom
sham
treat
group
mice
iv
infect
hsv
influenza
l
monocytogen
day
later
ovaspecif
ctl
immun
determin
vivo
g
control
splenectom
mice
infect
e
coli
immun
solubl
ova
plu
ctl
immun
determin
day
spleen
repres
data
shown
mean
sem
n
mice
per
group
least
two
independ
experi
ns
signific
spleendepend
tcell
immun
wonder
whether
receptor
requir
induc
immun
paralysi
vivo
end
evalu
induct
antivir
ctl
immun
bacteri
dissemin
tripl
knockout
mice
bear
simultan
defici
mice
found
inhibit
ctl
immun
gramneg
bacteria
figur
identifi
relev
individu
tlr
challeng
singl
knockout
mice
intraven
e
coli
determin
induct
antivir
ctl
immun
surprisingli
mice
neither
mice
mount
antivir
ctl
immun
follow
gramneg
sepsi
figur
demonstr
sepsi
crucial
inhibit
antimicrobi
ctl
immun
appar
discrep
effect
tlr
ligand
gramneg
sepsi
develop
immun
paralysi
may
relat
distinct
mechan
employ
differ
cell
popul
sens
solubl
tlr
ligand
bacteri
infect
transmit
signal
via
two
adapt
molecul
trif
next
character
individu
contribut
adapt
molecul
inhibit
antivir
ctl
immun
use
mice
defici
either
trif
gramneg
sepsi
still
impair
ctl
immun
mice
figur
observ
gener
strong
antivir
ctl
immun
trif
mice
figur
result
identifi
domin
far
unknown
function
inhibit
adapt
immun
trifdepend
fashion
earli
phase
gramneg
sepsi
given
known
regulatori
function
contribut
immun
paralysi
patient
dock
et
al
given
activ
imped
antivir
ctl
immun
vivo
figur
first
investig
contribut
model
system
unexpectedli
mice
ctl
immun
still
suppress
follow
infect
gramneg
bacteria
figur
clearli
demonstr
reason
impair
develop
ctl
immun
identifi
factor
caus
paralysi
adapt
immun
systemat
investig
event
downstream
trif
signal
trif
known
potent
caus
induct
type
ifn
express
beutler
kawai
akira
role
type
ifn
innat
immun
earli
sepsi
controversi
report
promot
karaghiosoff
et
al
huy
et
al
prevent
kellyscumpia
et
al
patholog
differ
model
septic
shock
role
type
ifn
adapt
immun
sepsi
investig
use
mice
defici
receptor
type
ifn
ifnar
character
relev
type
ifn
regul
ctl
immun
bacteri
sepsi
mice
observ
modest
induct
antivir
ctl
immun
gramneg
sepsi
increas
compar
litterm
still
reduc
compar
mice
subject
gramneg
sepsi
figur
indic
partial
recoveri
immun
paralysi
absenc
type
ifn
signal
interestingli
contrast
b
iv
inject
e
coli
c
e
trif
mice
day
infect
adova
ovaspecif
ctl
immun
determin
day
spleen
data
shown
n
mice
per
group
repres
data
least
two
independ
experi
shown
ns
signific
figur
howev
like
e
colimedi
suppress
suppress
ctl
immun
ligand
independ
figur
reason
understood
right
although
ligand
express
e
coli
ctl
suppress
ligand
function
order
dissoci
cellintrins
effect
trifinduc
express
type
ifn
mediat
directli
ifn
respons
factor
autocrineparacrin
signal
via
ifnar
mediat
intraven
inject
mice
e
coli
follow
adenoviru
compar
wildtyp
litterm
observ
partial
recoveri
ctl
immun
either
knockout
mous
line
figur
consist
synergist
role
induct
type
ifn
signal
honda
et
al
observ
also
synergist
effect
inhibit
develop
ctl
immun
use
doubl
knockout
mice
figur
collect
result
assign
novel
role
type
ifn
induc
signal
neg
regul
ctl
immun
mediat
via
synergist
activ
experiment
result
rais
question
cell
type
affect
type
ifn
discrimin
whether
ctl
directli
incapacit
type
ifn
whether
expans
ctl
crossprim
dc
affect
first
determin
number
ovaspecif
ctl
mice
inject
gramneg
bacteria
adova
infect
mice
suffer
sepsi
prior
viral
infect
suppress
ctl
activ
correl
sever
reduct
expans
virusspecif
ctl
figur
contrast
mice
inject
e
coli
adenovir
infect
ctl
immun
increas
correl
slightli
increas
virusspecif
ctl
expans
figur
base
result
specul
type
ifn
critic
role
type
ifn
e
colimedi
inhibit
ctl
immun
iv
inject
e
coli
b
ifnar
mice
day
iv
challeng
adova
c
ifnar
mice
either
left
untreat
receiv
cpgdna
day
prior
adova
infect
ovaspecif
ctl
immun
determin
day
spleen
data
shown
n
mice
per
group
repres
data
least
two
independ
experi
shown
cytokin
impair
dc
function
crosspresent
product
stimulatori
cytokin
inde
pretreat
mice
recombin
ifnab
abl
suppress
ctl
immun
similar
e
coli
figur
unlik
inject
e
coli
day
adova
inject
type
ifn
day
adova
significantli
improv
ctl
activ
figur
figur
interestingli
dc
isol
septic
nonsept
mice
reveal
differ
absolut
number
crosspres
dc
even
upregul
mhci
mhcii
molecul
essenti
tcell
activ
supplementari
figur
result
impli
system
bacteria
neither
delet
dc
downregul
mhc
molecul
need
antigen
present
besid
affect
crosspresent
type
ifn
also
impair
product
detect
ex
vivo
splenic
dc
figur
demonstr
type
ifn
induc
e
coli
sever
impair
dc
function
furthermor
support
invivo
data
data
literatur
longman
et
al
pretreat
bmdc
type
ifn
also
led
reduct
crossprim
naiv
cell
vitro
figur
similar
exvivo
data
antigen
uptak
mhc
ii
express
affect
type
ifn
supplementari
figur
confirm
immun
regulatori
role
type
ifn
dc
exclud
direct
suppress
effect
cell
studi
whether
ctl
immun
develop
challeng
e
coli
mice
lack
ifnar
select
cell
cell
interestingli
septic
mice
lack
ifnar
dc
mice
lack
ifnar
cell
normal
antivir
ctl
respons
gener
figur
result
demonstr
dc
key
target
cell
popul
immun
regulatori
function
type
ifn
tcell
help
critic
induct
adenovirusspecif
ctl
immun
supplementari
figur
e
coli
inject
impair
gener
helpdepend
igg
product
supplementari
figur
next
investig
role
cell
sepsisinduc
paralysi
ctl
immun
importantli
sepsisinduc
inhibit
ctl
immun
prevent
vivo
preexist
tcell
help
gener
prior
vaccin
mice
mhc
class
ii
bind
ova
peptid
known
induc
strong
tcell
respons
figur
bonifaz
et
al
boscardin
et
al
order
differenti
whether
tcell
help
act
directli
dc
overcom
inhibitori
effect
type
ifn
target
antigen
directli
dc
use
combin
antibodi
known
function
matur
dc
mimick
tcell
help
bonifaz
et
al
bevan
boscardin
et
al
kurt
et
al
although
treatment
effici
induc
ctl
immun
untreat
mice
indic
function
matur
dc
treatment
prevent
inhibit
antivir
ctl
immun
sepsi
figur
indic
dc
sever
impair
type
ifn
function
stimul
cell
moreov
observ
reduc
mhcii
restrict
present
naiv
cell
treatment
immatur
dc
type
ifn
vitro
figur
suggest
type
ifn
render
dc
nonrespons
cellmedi
matur
also
alreadi
impair
gener
tcell
help
act
synergist
inhibit
ctl
immun
figur
inhibit
dc
function
gener
ctl
immun
like
consequ
combin
direct
signal
signal
trigger
bind
type
ifn
ifnar
dc
combin
complet
recoveri
function
dc
lack
ifnar
express
suggest
type
ifn
produc
cell
type
respons
signal
might
act
dc
identifi
cell
popul
produc
type
ifn
examin
cellular
distribut
spleen
system
circul
recombin
bacteria
gain
fluoresc
activ
phagocyt
uptak
bacteria
found
margin
zone
spleen
vicin
macrophag
figur
local
express
type
ifn
within
margin
zone
respons
bacteria
suggest
strong
express
ifnsensit
mxa
protein
figur
directli
detect
measur
type
ifn
gene
express
rtpcr
figur
express
level
type
ifn
spleen
figur
left
panel
directli
correl
inhibit
ctl
immun
figur
right
panel
directli
character
relev
phagocyt
cell
type
ifnmedi
immun
paralysi
deplet
macrophag
clodron
liposom
wait
day
allow
dc
recov
deplet
macrophag
persist
backer
et
al
inject
mice
intraven
e
coli
interestingli
clodron
treatment
abrog
sepsisinduc
express
type
ifn
spleen
figur
suggest
macrophag
instrument
suppress
tcell
immun
consequ
absenc
macrophag
dc
target
abl
mount
antivir
ctl
immun
sepsi
figur
import
macrophag
suppress
ctl
immun
demonstr
experi
use
mice
lack
ifnar
macrophag
lysmcr
ifnar
flfl
similarli
mice
lack
ifnar
dc
ctl
respons
septic
mice
lack
figur
type
ifn
block
dc
abil
induc
antimicrobi
ctl
immun
mice
receiv
e
coli
iv
either
day
day
infect
adova
day
later
cytotox
activ
right
panel
correl
frequenc
ovaspecif
ctl
determin
b
pentam
stain
left
panel
b
mice
receiv
e
coli
iu
ifnab
iv
day
ifnab
day
infect
adova
cytotox
respons
determin
day
later
spleen
c
cell
isol
spleen
h
adova
infect
control
mice
mice
pretreat
e
coli
cell
coincub
oti
cell
supernat
analys
elisa
dc
control
mice
mice
inject
e
coli
ifnab
isol
h
later
spleen
restimul
cpgdna
vitro
supernat
analys
h
later
elisa
e
immatur
bmdc
treat
unitsml
ifnab
h
follow
incub
indic
concentr
ova
h
tcell
activ
determin
elisa
supernat
incub
dc
e
oti
otii
cell
f
ovaspecif
ctl
immun
determin
ifnar
flfl
mice
mice
either
left
untreat
inject
iv
e
coli
day
prior
infect
adova
g
mice
either
immun
sc
ova
deriv
iab
peptid
piccpgdna
left
untreat
seven
day
later
indic
mice
inject
iv
e
coli
infect
adova
h
later
ovaspecif
ctl
immun
determin
day
later
h
one
day
mice
receiv
combin
mg
iv
mg
mice
inject
iv
e
coli
left
untreat
five
day
later
ovaspecif
ctl
immun
determin
spleen
data
shown
n
mice
per
group
repres
data
least
two
independ
experi
shown
ifnar
macrophag
longer
suppress
figur
result
demonstr
macrophag
control
ctl
immun
transfer
antigen
dc
backer
et
al
also
regul
tcell
activ
via
type
ifn
figur
clearli
show
macrophag
respons
product
type
ifn
interact
bacteria
littl
type
ifn
express
detect
ifnar
express
absent
dc
macrophag
cell
figur
like
explain
amplifi
posit
feed
forward
loop
macrophag
dc
increas
initi
ifn
respons
taken
togeth
find
support
notion
sepsi
macrophag
dc
contribut
amplif
type
ifn
express
turn
neg
regul
abil
dc
mount
ctl
immun
bacteri
sepsi
sever
complic
system
infect
divid
two
phase
first
phase
character
initi
overwhelm
inflammatori
respons
second
phase
character
stain
green
phrodo
e
coli
bioparticl
red
b
mice
mice
express
mxa
protein
infect
e
coli
iv
day
bacteri
infect
mxa
protein
detect
immunohistochemistri
one
mous
three
group
depict
origin
magnif
small
panel
c
mice
infect
increas
dose
e
coli
inject
pb
half
mice
rel
express
measur
quantit
pcr
spleen
tissu
h
later
left
panel
half
infect
adova
h
later
ctl
immun
determin
spleen
day
right
panel
day
inject
e
coli
mice
deplet
macrophag
clodron
liposom
inject
pb
rel
express
measur
quantit
pcr
spleen
tissu
h
later
e
macrophag
wt
mice
deplet
clodron
liposom
ml
iv
seven
day
deplet
mice
infect
iv
e
coli
left
untreat
one
day
infect
mice
immun
iv
mg
mg
ovaspecif
ctl
immun
determin
spleen
day
immun
f
ovaspecif
ctl
immun
determin
lysmcr
ifnar
flfl
mice
mice
either
left
untreat
inject
iv
e
coli
day
prior
infect
adova
g
ifnar
flfl
lysmcr
ifnar
flfl
ifnar
mice
either
left
untreat
receiv
e
coli
iv
six
hour
later
rel
express
measur
quantit
pcr
spleen
tissu
data
normal
arithmet
mean
dc
valu
wildtyp
mice
data
shown
mean
sem
n
mice
per
group
ns
signific
inabl
mount
protect
adapt
immun
respons
secondari
microbi
infect
show
follow
gramneg
sepsi
mice
develop
immun
paralysi
fail
mount
ctl
immun
viral
adenoviru
hsv
influenza
viru
bacteri
infect
l
monocytogen
septic
immun
paralysi
depend
recognit
bacteria
trifmedi
signal
via
induc
type
ifn
macrophag
directli
incapacit
dc
present
antigen
activ
cell
recent
identifi
spleen
critic
induct
adapt
tcell
immun
system
viral
infect
backer
et
al
shown
spleen
tcell
activ
dc
strictli
depend
antigen
transfer
mmm
dc
unknown
mechan
oper
splenic
margin
zone
backer
et
al
report
septic
paralysi
tcell
immun
observ
bacteria
dissemin
suffici
high
number
via
blood
stream
spleen
indic
suppress
mechan
act
mostli
spleen
hypothesi
support
report
show
spleen
central
affect
bacteri
sepsi
cohen
hotchkiss
karl
hotchkiss
et
al
far
immun
paralysi
describ
result
irrevers
chang
splenic
architectur
deplet
immun
cell
occur
late
consequ
bacteri
sepsi
cohen
hotchkiss
karl
hotchkiss
et
al
result
demonstr
howev
least
earli
time
point
sir
immun
paralysi
revers
state
yet
caus
cell
deplet
function
inhibit
dc
mechanist
identifi
macrophag
key
cell
popul
sens
system
bacteria
suppress
dc
function
secret
type
ifn
therebi
prevent
gener
tcell
immun
type
ifn
initi
produc
macrophag
margin
zone
spleen
absenc
ifnar
either
cell
popul
e
coli
induc
much
less
type
ifn
conclud
initi
weak
type
ifn
respons
amplifi
concert
action
macrophag
dc
new
regulatori
function
macrophag
nice
add
alreadi
known
function
macrophag
ie
macrophag
activ
context
microbi
infect
undergo
two
phase
initi
stimul
immun
product
proinflammatori
mediat
tnf
later
time
point
inhibit
innat
adapt
immun
express
consequ
patient
suffer
sepsi
increas
level
measur
serum
directli
correl
observ
impair
adapt
immun
furthermor
convincingli
shown
monocyt
septic
patient
exhibit
decreas
express
mhc
ii
molecul
inabl
produc
tnf
dock
et
al
volk
et
al
despit
clear
associ
septic
immun
paralysi
immun
paralysi
observ
earli
time
point
sepsi
clearli
depend
type
ifn
suggest
distinct
phase
septic
immun
paralysi
exist
seem
govern
differ
molecular
mechan
earli
phase
regul
type
ifn
caus
revers
suppress
adapt
immun
later
phase
character
delet
immun
cell
overal
irrevers
chang
spleen
cohen
hotchkiss
karl
hotchkiss
et
al
involv
point
macrophag
sens
gramneg
bacteria
surpris
instrument
sens
bacteri
infect
lead
earli
septic
immun
paralysi
although
gramneg
bacteria
principl
sens
varieti
tlr
recogn
structur
compon
respect
death
gramneg
septic
shock
induc
massiv
bacteri
load
report
also
depend
exclus
roger
et
al
indic
receptor
essenti
phase
sepsi
inflammatori
immun
paralysi
phase
howev
death
inflammatori
phase
involv
adapt
molecul
downstream
trif
weighardt
et
al
weighardt
et
al
immun
paralysi
earli
septic
immun
paralysi
occur
respons
trifmedi
signal
consist
type
ifn
regulatori
mediat
suppress
type
ifn
pleiotroph
effect
report
promot
proinflammatori
well
antiinflammatori
respons
biron
trinchieri
among
other
complex
type
ifn
activ
demonstr
clinic
use
either
attenu
autoimmun
multipl
sclerosi
increas
tcell
immun
chronic
hepat
b
c
trinchieri
without
doubt
type
ifn
strong
activ
adapt
immun
stimul
dc
cell
biron
curtsing
et
al
longhi
et
al
trinchieri
among
mani
report
describ
immun
stimulatori
role
type
ifn
report
clearli
demonstr
type
ifn
stimul
ctl
immun
enhanc
dc
differenti
matur
hoeb
et
al
honda
et
al
improv
crossprim
le
bon
et
al
dunn
et
al
directli
stimul
tcell
prolifer
signal
curtsing
et
al
hand
type
ifn
shown
inhibit
antivir
immun
block
dc
differenti
precursor
cell
hahm
et
al
inhibit
crosspresent
vitro
longman
et
al
induc
refractori
state
dc
zuniga
et
al
ad
list
report
ascrib
neg
regulatori
role
type
ifn
report
novel
neg
regulatori
function
type
ifn
inhibit
dc
function
earli
gramneg
sepsi
type
ifn
jeopard
antivir
well
antibacteri
ctl
immun
paradox
type
ifn
stimulatori
suppress
explain
observ
suggest
type
ifn
distinct
effect
depend
differenti
statu
dc
time
point
locat
ifn
product
respect
observ
system
e
coli
suppress
inject
adova
infect
rather
stimulatori
inject
adova
infect
furthermor
suppress
effect
e
coli
could
replac
recombin
type
ifn
prove
suppress
potenti
given
antigen
challeng
line
observ
also
group
report
paradox
effect
type
ifn
hahm
et
al
longman
et
al
author
explain
seemingli
contradict
effect
type
ifn
correl
stimulatori
suppress
function
type
ifn
usag
differ
stat
molecul
downstream
ifnar
hahm
et
al
longman
et
al
convincingli
show
immatur
dc
ifnar
associ
suppress
matur
dc
ifnar
associ
activ
type
ifn
data
explain
cytokin
oppos
effect
immatur
dc
situat
splenic
margin
zone
conceiv
sepsi
type
ifn
produc
margin
zone
macrophag
strongli
suppress
immatur
margin
zone
dc
activ
dc
alreadi
migrat
tcell
zone
stimul
type
ifn
stimulatori
inhibitori
mediat
secret
macrophag
allow
clear
distinct
signal
molecular
level
interest
specul
dual
function
type
ifn
immun
respons
evolv
spleen
dual
role
mount
immun
microbi
infect
time
elimin
die
senesc
cell
cellular
debri
blood
circul
tissu
damag
cell
death
caus
releas
endogen
danger
signal
caus
steril
inflamm
signal
rage
sim
et
al
yang
et
al
massiv
system
inflamm
might
eventu
trigger
autoimmun
activ
autoreact
cell
via
dc
present
autoantigen
possibl
explan
seemingli
paradox
role
type
ifn
adapt
immun
might
relat
time
point
type
ifn
act
antigenpres
cell
ampl
evid
presenc
type
ifn
antigen
present
cell
lead
immun
data
suggest
tempor
dissoci
type
ifn
product
antigen
present
result
inhibit
dc
function
reason
correct
allow
immun
system
differenti
danger
pathogen
selfprotein
simpli
pathogen
would
provid
signal
simultan
antigen
pamp
wherea
selfantigen
hypothesi
locotempor
differenti
self
nonself
support
report
convincingli
show
tcell
activ
alreadi
prevent
antigen
tlr
ligand
present
apc
separ
differ
vesicl
blander
medzhitov
thu
specul
mechan
report
evolv
failsaf
mechan
protect
autoimmun
infect
therefor
develop
autoimmun
individu
follow
infect
may
relat
failur
type
ifnmedi
control
dc
function
respect
sepsi
induct
immun
paralysi
via
may
repres
accident
activ
failsaf
mechan
system
bacteria
express
molecular
structur
resembl
endogen
ligand
cohen
hotchkiss
karl
hotchkiss
et
al
final
sinc
type
ifn
also
deleteri
effect
earli
inflammatori
phase
sepsi
karaghiosoff
et
al
weighardt
et
al
addit
macrophagederiv
type
ifn
key
mediat
ctl
immun
paralysi
sepsi
cell
typespecif
knockdown
strategi
target
andor
trifinduc
type
ifn
express
macrophag
may
exploit
improv
immun
statu
patient
suffer
sepsi
mice
purchas
janvier
franc
experi
perform
use
wildtyp
mice
mxa
transgen
mice
wenzel
et
al
mice
defici
hemmi
et
al
trif
yamamoto
et
al
adachi
et
al
kuhn
et
al
honda
et
al
steinberg
et
al
ifnar
van
den
broek
et
al
iab
cosgrov
et
al
defici
ifnar
select
cell
ifnar
flfl
macrophag
lysmcr
ifnar
flfl
cervant
barragan
et
al
mice
bred
background
accord
institut
anim
guidelin
specif
pathogenfre
condit
local
anim
facil
hous
experiment
therapi
het
univers
bonn
mous
studi
approv
local
regulatori
agenc
lanuv
nrw
rpmi
medium
sigma
munich
germani
supplement
fc
paa
germani
penicillinstreptomycin
lonza
cologn
germani
lglutamin
paa
mm
bmercaptoethanol
sigma
use
dctcell
cocultur
peptid
pineda
germani
dissolv
mm
stock
solut
dmso
store
tlrl
tib
molbiol
berlin
ultrapur
lp
invivogen
franc
pic
sigma
ifnab
purchas
r
deplet
macrophag
mice
receiv
ml
clodron
liposom
iv
indic
time
point
casp
procedur
use
induct
septic
periton
describ
detail
previous
zantl
et
al
use
venou
cathet
insert
colon
ascenden
mm
distal
ileocaec
valv
mock
treatment
small
bowel
anim
subject
standard
surgic
manipul
im
intestin
mice
touch
cotton
swab
without
set
stent
therefor
mimick
complex
surgic
procedur
casp
treatment
schwarz
et
al
splenectomi
anaesthetis
mice
underw
laparotomi
spleen
remov
blood
vessel
ligat
mice
use
week
splenectomi
experi
escherichia
coli
express
lux
operon
e
coli
lux
wildtyp
e
coli
recombin
listeria
monocytogen
express
ova
lmova
cultur
h
luriabertani
broth
roth
karlsruh
contain
ampicillin
mgl
brain
heart
infus
broth
medium
roth
invivo
kill
e
coli
ampicillin
mgmous
inject
ip
h
e
coli
inject
coloni
form
unit
cfu
quantifi
determin
optic
densiti
nm
hk
e
coli
gener
min
incub
pathogen
reagent
gener
dilut
pb
experiment
infect
experiment
viral
infect
mice
infect
iv
viru
particl
recombin
replic
incompet
adenoviru
express
ovalbumin
adova
schweichel
et
al
pfu
hsv
type
pfu
influenza
viru
induct
ovaspecif
cytotox
mice
either
infect
iv
adova
inject
iv
mgmous
mgmous
solubl
ova
sigma
grade
v
combin
mgmous
antibodi
induct
ovaspecif
cell
endogen
ovaspecif
cell
activ
vivo
mg
ova
boscardin
et
al
mix
mg
mg
pi
c
subcutan
sc
immun
flank
day
adenoviru
infect
applic
rout
volum
intraven
ml
subcutan
ml
invivo
imag
mice
receiv
e
coli
lux
per
gavag
analys
inhal
anaesthesia
isofluran
use
live
imag
softwar
singl
cell
suspens
prepar
organ
press
organ
steril
siev
mm
ml
cell
suspens
plate
select
macconkey
agar
h
cfu
calcul
per
organ
per
gram
tissu
respect
phrodo
tm
e
coli
bioparticl
inject
iv
mice
spleen
remov
h
later
histolog
analysi
spleen
fix
min
pfa
transfer
pb
contain
